All lobbying filings

MARBLE ARCH

Lobbying for ON DEMAND PHARMACEUTICALS · Pharmaceutical manufacturing

Filing 4th Quarter - Termination

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 7, 2026

Income

$20,000.00

What the client paid this registrant for the period.

Client based in

Maryland

Representation ended

Dec 1, 2025

The registrant reported terminating its work for this client.

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 1

Pharmacy

Issues relating to securing the domestic pharmaceutical supply chain, ensuring reliable access to essential medications, and manufacturing of high-quality generic drugs in America.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.